Clinical Trials Directory

Trials / Completed

CompletedNCT00324207

Molecular Quantification of Insulin mRNA

Prediction of Type 1 Diabetes: Molecular Quantification of Insulin mRNA in the While Cell Fraction of Whole Blood

Status
Completed
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Children's Mercy Hospital Kansas City · Academic / Other
Sex
All
Age
1 Year – 17 Years
Healthy volunteers
Accepted

Summary

The objectives of this study are to: 1. quantitate the level of insulin mRNA in the while cell fraction of whole blood in selected groups of subjects, 2. determine the gene expression of markers of white cell activation in the white cell fraction of whole blood in selected subjects, 3. determine the identity of the white cell responsible for expression of insulin mRNA and 4. determine protein expression of mRNA of insulin/proinsulin and selected genes of white cell activation.

Detailed description

Indicators of active immune or chemically mediated beta cell destruction would be helpful for predicting the development and severity of autoimmune diabetes and monitoring the success of islet transplants. Currently there are no reliable indicators readily available. Insulin mRNA in the white cell fraction of blood has been detected or elevated under several circumstances including: 1. normal animals 2. after islet cell transplantation 3. hyperglycemic induced expression and 4. during induction of diabetes with streptozotocin The investigators propose that quantitative measurement of insulin mRNA may be an accurate, innovative and minimally invasive indicator of beta cell destruction.

Conditions

Timeline

Start date
2006-02-01
Primary completion
2009-01-01
Completion
2009-01-01
First posted
2006-05-10
Last updated
2010-03-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00324207. Inclusion in this directory is not an endorsement.